Published in Methods Enzymol on January 01, 2000
Modern analytical ultracentrifugation in protein science: a tutorial review. Protein Sci (2002) 4.86
Crystal structure and association behaviour of the GluR2 amino-terminal domain. EMBO J (2009) 2.19
Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface. J Virol (2002) 1.69
The human immunodeficiency virus type 1 gp120 V2 domain mediates gp41-independent intersubunit contacts. J Virol (2000) 1.47
Oligomeric structure of virion-associated and soluble forms of the simian immunodeficiency virus envelope protein in the prefusion activated conformation. Proc Natl Acad Sci U S A (2001) 1.30
Solution structure, conformational dynamics, and CD4-induced activation in full-length, glycosylated, monomeric HIV gp120. J Virol (2012) 1.21
Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras. J Virol (2004) 1.03
All-atom ensemble modeling to analyze small-angle x-ray scattering of glycosylated proteins. Structure (2013) 0.96
Reversibly bound chloride in the atrial natriuretic peptide receptor hormone-binding domain: possible allosteric regulation and a conserved structural motif for the chloride-binding site. Protein Sci (2010) 0.85
Fibulin 5 forms a compact dimer in physiological solutions. J Biol Chem (2009) 0.83
Purification of recombinant vaccinia virus-expressed monomeric HIV-1 gp120 to apparent homogeneity. Protein Expr Purif (2013) 0.79
Human herpesvirus 7 U21 tetramerizes to associate with class I major histocompatibility complex molecules. J Virol (2014) 0.76
In vitro synthesis of full-length DNA transcripts of Rous sarcoma virus RNA by viral DNA polymerase. Proc Natl Acad Sci U S A (1975) 2.68
Heteroduplex analysis of avian RNA tumor viruses. Proc Natl Acad Sci U S A (1977) 2.59
Retroviral DNA H structures: displacement-assimilation model of recombination. Cell (1982) 2.37
A humanized antibody that binds to the interleukin 2 receptor. Proc Natl Acad Sci U S A (1989) 2.23
A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature (1989) 2.13
Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac. Blood (1995) 1.99
Comparison between the viral transforming gene (src) of recovered avian sarcoma virus and its cellular homolog. Mol Cell Biol (1981) 1.78
Products of reverse transcription in avian retrovirus analyzed by electron microscopy. J Virol (1982) 1.47
RNA leaching of transcription factors disrupts transcription in myotonic dystrophy. Science (2003) 1.44
The multichain interleukin-2 receptor: a target for immunotherapy. Ann Intern Med (1992) 1.19
Electron microscopic analysis of ts1 10 Moloney mouse sarcoma virus, a variant of wild-type virus with two RNAs containing large deletions. J Mol Biol (1982) 1.10
The role of the Brambell receptor (FcRB) in liver: protection of endocytosed immunoglobulin G (IgG) from catabolism in hepatocytes rather than transport of IgG to bile. Immunology (2000) 1.09
Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptors. Neoplasia (2001) 1.06
Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA. Clin Cancer Res (1999) 1.04
Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer. Cancer Res (2001) 1.02
Amplification of IgG VH and VL (Fab) from single human plasma cells and B cells. Nucleic Acids Res (2000) 1.00
Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity. Cancer Res (1989) 0.97
Coupling CD28 co-stimulation to immunoglobulin T-cell receptor molecules: the dynamics of T-cell proliferation and death. J Immunother (2001) 0.92
Chimeric immune receptors (CIRs) specific to JC virus for immunotherapy in progressive multifocal leukoencephalopathy (PML). Int Immunol (2007) 0.91
IgG biosynthesis: no "immunoregulatory feedback". Blood (1997) 0.90
Dynamics of tumor cell killing by human T lymphocytes armed with an anti-carcinoembryonic antigen chimeric immunoglobulin T-cell receptor. J Immunother (2000) 0.88
Antileukemic effect of daclizumab in CD25 high-expressing leukemias and impact of tumor burden on antibody dosing. Leuk Res (2005) 0.86
Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival. Proc Natl Acad Sci U S A (1991) 0.85
Sorting vector producer cells for high transgene expression increases retroviral titer. J Virol Methods (2008) 0.85
An optimized method for cell-based phage display panning. Immunotechnology (1997) 0.83
Anti-CD30 antibody-based therapy. Curr Opin Oncol (2000) 0.83
A single-chain immunotoxin against carcinoembryonic antigen that suppresses growth of colorectal carcinoma cells. Clin Cancer Res (1998) 0.81
A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells. J Immunol (1994) 0.81
Screening of phage display immunoglobulin libraries by anti-M13 ELISA and whole phage PCR. Nucleic Acids Res (1995) 0.80
An advanced solid support for immunoassays and other affinity applications. Biotechniques (1993) 0.80
Focused antibody response in plasma cell-infiltrated non-medullary (NOS) breast cancers. Breast Cancer Res Treat (2007) 0.79
Biventricular cardiac thrombosis during interleukin-2 infusion. N Engl J Med (2001) 0.79
Lymphokine receptor-directed therapy: a model of immune intervention. J Clin Immunol (1990) 0.78
Measurement and biological correlates of antibody bioactivity during antibody immunotherapies. J Immunol Methods (1998) 0.77
A review of the toxicity of methylmercury compounds with application to occupational exposures associated with laboratory uses. Environ Res (1983) 0.75
Anti-Gal antibodies-where's the beef? Nat Biotechnol (1999) 0.75
Falstaff was drunker than he was fat. N Engl J Med (1983) 0.75
Mercury in the ocean. Science (1980) 0.75
Direct immunoprecipitation of antigen with phage displaying immunoglobulin fragment. Biotechniques (2000) 0.75
Interleukin 2 maintains biologic stability and sterility over prolonged time. Immunopharmacology (2000) 0.75
Next-generation Fc chimeric proteins: avoiding immune-system interactions. Trends Biotechnol (1997) 0.75
High-dose intravenous gamma globulin to suppress alloimmune destruction of donor platelets. Am J Med (1984) 0.75
Statistical procedures in electron microscopy. J Mol Biol (1982) 0.75
A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells. J Hematother (1995) 0.75
Examination of a role for idiotypy in the disease remission of a long-term survivor of adult T cell leukemia treated with anti-Tac antibody. Leukemia (1998) 0.75